Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.56 +0.04 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.52 | 52 Week High | $18.00 | |||
| Open | $4.48 | 52 Week Low | $6.91 | |||
| Day High | $4.64 | P/E | N/A | |||
| Day Low | $4.44 | EPS | $-0.67 | |||
| Volume | 758,140 | |||||
